From August 15–17, 2025, VinaBiocare was honored to accompany the 8th National Neurology Scientific Congress, held in Vung Tau City.

This prestigious scientific event brought together experts, doctors, and researchers in the field of neurology to update the latest advances in the diagnosis, treatment, and prevention of neurological disorders. Among the key topics, dementia and Alzheimer’s disease attracted significant interest from attendees.

At the conference, VinaBiocare introduced the One Step Dementia Test Kit – an innovative tool for early detection of dementia risk. The product stands out for being non-invasive, easy to use, and providing rapid and accurate results, enabling early screening and timely intervention to enhance brain health management and care efficiency.

One Step Dementia Risk Test Kit is a screening tool designed to detect the risk of dementia (including but not limited to Alzheimer’s disease). It is used to qualitatively analyze biochemical indicators of amyloid-β protein in human urine. This kit can help physicians determine whether further testing is necessary, evaluate disease progression, and assess treatment effectiveness related to brain health.

Through its participation in the Congress, VinaBiocare reaffirmed its commitment to delivering advanced medical solutions, contributing to community efforts in the prevention and early detection of dementia-related diseases.